Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EC-313 by Evestra for Endometriosis: Likelihood of Approval
EC-313 is under clinical development by Evestra and currently in Phase I for Endometriosis. According to GlobalData, Phase I drugs...
Data Insights
EC-313 by Evestra for Uterine Leiomyoma (Uterine Fibroids): Likelihood of Approval
EC-313 is under clinical development by Evestra and currently in Phase I for Uterine Leiomyoma (Uterine Fibroids). According to GlobalData,...